Mesenchymal niche-specific expression of Cxcl12 controls quiescence of treatment-resistant leukemia stem cells

Chronic myeloid leukemia (CML) originates in a hematopoietic stem cell (HSC) transformed by the BCR-ABL oncogene and is effectively treated with tyrosine kinase inhibitors (TKIs). TKIs do not eliminate disease-propagating leukemic stem cells (LSC), suggesting a deeper understanding of niche-dependen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Stem Cell
Egile Nagusiak: Agarwal, Puneet, Isringhausen, Stephan, Li, Hui, Paterson, Andrew J., He, Jianbo, Gomariz, Álvaro, Nagasawa, Takashi, Nombela-Arrieta, César, Bhatia, Ravi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499704/
https://ncbi.nlm.nih.gov/pubmed/30905620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stem.2019.02.018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak